Authored By: Sarah
11 Jul 2024

 Atrial Fibrillation Surgery Market Size to grow by USD 1993.8 million between 2024-2028

According to a research report “ Atrial Fibrillation Surgery Market” by Product (Catheter ablation, Surgical ablation) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 1993.8 million, at a CAGR of  14.76% during the forecast period. In the global healthcare market, advancements in technology have driven atrial fibrillation (AF) surgery vendors to innovate next-generation ablation catheters. Previous devices, equipped with large electrodes, offered imprecise information and prolonged procedural duration. Boston Scientific's IntellaTip MiFi XP Temperature Ablation Catheter, utilizing MicroFidelity (MiFi) sensor technology and mini electrodes, addresses these challenges. This advanced device delivers high-resolution imaging of heart tissues, enabling surgeons to accurately identify arrhythmia locations, thereby enhancing procedure effectiveness and efficiency, while ensuring safety and cost-effectiveness.

Browse market data tables, figures, and in-depth TOC on “Atrial Fibrillation Surgery Market” by Product (Catheter ablation, Surgical ablation) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample


By Product, the Catheter ablation segment is projected to dominate the market size in 2024


By Geography, North America  segment is expected to hold the largest market size for the year 2024

In the healthcare industry, cardiac arrhythmias represent a significant challenge due to their irregular and abnormal heart rhythms, which can manifest as less than 60 beats per minute, more than 100 beats per minute, or an irregular rhythm. These arrhythmias are caused by dysfunctions in the electrical systems that regulate the heart, leading to conditions such as atrial fibrillation, atrial flutter, and atrioventricular nodal re-entrant tachycardia. Symptoms of these conditions include chest pain, shortness of breath, fatigue, dizziness, and fainting. The increasing prevalence of cardiac arrhythmias and the subsequent demand for effective treatment options have driven the growth of the catheter ablation market. This segment of the market has experienced double-digit growth due to the non-invasive nature and success rates of catheter ablation procedures in treating arrhythmias. Catheter ablation is a specialized medical intervention that utilizes catheters to detect and treat congenital heart abnormalities, providing a less invasive alternative to traditional surgical procedures.

North America is forecasted to hold the largest market size by region in 2024

The Atrial Fibrillation Surgery Market represents a significant business opportunity due to the rising prevalence of atrial fibrillation (AF) globally. This cardiac condition increases the risk of stroke and heart failure, necessitating effective treatment methods. Surgical interventions, such as catheter ablation and surgical ablation, offer promising solutions for AF patients. Market growth is driven by advancements in technology, increasing awareness, and favorable reimbursement policies. Companies focusing on innovative solutions and strategic collaborations will likely capture a larger market share.

The Atrial Fibrillation Surgery Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Abbott Laboratories
  • AngioDynamics Inc.
  • AtriCure Inc.
  • Avanos Medical Inc.
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corp.
  • CardioFocus Inc.
  • General Electric Co.
  • Johnson and Johnson Services Inc.
  • Koninklijke Philips N.V.
  • Lepu Medical Technology Beijing Co. Ltd.
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • Siemens Healthineers AG
  • Stereotaxis Inc.
  • Teleflex Inc.
  • Tempus Labs Inc.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Atrial Fibrillation (AF) Surgery Market is witnessing significant growth due to the increasing prevalence of heart diseases, particularly AF, and the rising demand for minimally invasive surgical procedures. Skilled labor is essential for performing complex AF surgeries, including surgical ablation and catheter ablation. Regulatory issues, such as data requirements and regulatory policies, pose challenges to market growth. Atrial fibrillation therapeutics, such as OSA (Obstructive Sleep Apnea) devices from Northwell Health and Peerbridge Health, offer alternatives to surgery. Advanced automotive features, like continuous data collection, are being integrated into remote patient monitoring systems to improve AF treatment. Key players in the market include Isolator Synergy, with its Sensei X System, and EnCompass Clamp, which simplifies AF surgery. The Heart Association emphasizes the importance of early diagnosis and treatment of AF, arrhythmia, and cardiovascular disorders. The treatment cost of AF surgery remains high, increasing competition among market players. The prevalence of obesity and its link to AF further fuel market growth. Overall, the AF Surgery Market is expected to continue its expansion, driven by technological advancements and the increasing burden of heart rhythm disorders.

Market Research Overview

Atrial Fibrillation (AF) is a common heart rhythm disorder characterized by irregular and often rapid heartbeats. Diagnosis is typically made through an Electrocardiogram (ECG), which can detect the irregular heart rhythm. For treating AF, various ablation strategies are used, including catheter ablation and surgical ablation. The ECGenius System and CathVision are advanced tools used in catheter ablation procedures. AVNRT, a type of atrial arrhythmia, is also treated with similar ablation techniques. Stroke is a major complication of AF, making the development of Atrial Fibrillation Surgery Market crucial. Customized services, such as HST One and HST Pathways, offer speedy recovery and accuracy in AF surgery. Minimally invasive surgeries, like those using the HST One system, reduce injury and surgical pain. However, regulatory issues and skilled labor requirements add to the treatment cost. Heart diseases like atherosclerosis, heart failure, and obesity increase the prevalence of AF in the geriatric population. Atrial Fibrillation Therapeutics, Northwell Health, Peerbridge Health, Isolator Synergy, and EnCompass Clamp are significant players in the market. Competition is intense, with data requirements and regulatory policies shaping the market landscape. Remote patient monitoring, ICU care, and telehealth services are essential for managing acute cardiac rhythm disturbances like AF. Continuous data and advanced automotive features enable healthcare providers to monitor patients effectively. However, challenges like acute respiratory distress, shock, myocarditis, and cardiovascular disorders remain. The American Heart Association emphasizes the importance of timely diagnosis and treatment of AF to prevent complications and improve patient outcomes.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!